Myfortic (Avera McKennan Hospital)


Welcome to the PulseAid listing for the Myfortic drug offered from Avera McKennan Hospital. This Antimetabolite Immunosuppressant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Avera McKennan Hospital
NON-PROPRIETARY NAME: mycophenolic acid
SUBSTANCE NAME: MYCOPHENOLATE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antimetabolite Immunosuppressant [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, DELAYED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-03-01
END MARKETING DATE: 0000-00-00


Myfortic HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMyfortic from Avera McKennan Hospital
LABELER NAME: Avera McKennan Hospital
DEA SCHEDULE:
ACTIVE STRENGTH: 180(mg/1)
START MARKETING DATE: 2015-03-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69189-0385_357a6afc-99d8-4fc9-bfd8-ad634a042999
PRODUCT NDC: 69189-0385
APPLICATION NUMBER: NDA050791

Other MYCOPHENOLATE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare Inc.Mycophenolic Acid
American Health PackagingMycophenolic Acid
Apotex CorpMycophenolic Acid
Avera McKennan HospitalMyfortic
Golden State Medical Supply, Inc.Mycophenolic Acid
Novartis Pharmaceuticals CorporationMyfortic